Clinical efficacy of gabapentin and carbamazepine in elderly patients with primary trigeminal neuralgia
10.3969/j.issn.1005-1678.2017.02.070
- VernacularTitle:加巴喷丁与卡马西平治疗老年原发性三叉神经痛患者的临床疗效观察
- Author:
Youjun YANG
;
Yunhua LI
- Keywords:
gabapentin;
carbamazepine;
primary trigeminal neuralgia
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(2):229-231
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical efficacy of gabapentin and carbamazepine in the treatment of elderly patients with primary trigeminal neuralgia.Methods 96 cases of elderly patients with primary trigeminal from March 2014 to March 2016 were selected and randomly divided into gabapentin group and carbamazepine group, which each group with 48 cases.The clinical efficacy, adverse reactions and changes of pain, insomnia, anxiety, depression status and oxidative stress indexes were compared.Results After treatment, there was no significant difference in total effective rate between two groups.And the excellence rates in gabapentin group was 60.4%, which significantly higher than that in carbamazepine group with 37.5%, the difference was statistically significant ( P <0.05 ) .After treatment, VAS score and sleep disturbance score in gabapentin group were significantly lower than those in carbamazepine group, the difference was statistically significant (P<0.05), and SAS score and SDS score were also significantly lower than those in carbamazepine group, the difference was statistically significant (P<0.05).The adverse reactions rates in gabapentin group was 22.9%, which significantly higher than that in carbamazepine group with 43.8%, the difference was statistically significant ( P <0.05 ) . Conclusion Compared with carbamazepine, gabapentin in the treatment of elderly patients with primary trigeminal neuralgia can enhance clinical effect , improve pain, insomnia, anxiety, depression status.
